Skip to main content

SOPH · SOPHiA GENETICS SA · Financials

Track SOPH — free
$8.39 +0.32 (+3.98%)
Market Cap
$709.97M
Shares
85.13M
Volume · Oct 5 1.18M Avg daily vol (3M) 525.46K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$77.27M +18.6%
FY2025 Revenue FY2019–FY2025
Net Income
-$79M -26.4%
FY2025 Net Income FY2019–FY2025
Gross Margin
67.4% 0pp
FY2025 Gross Margin FY2019–FY2025
Operating Margin
-91.76% +10.4pp
FY2025 Operating Margin FY2020–FY2025
Diluted EPS
-$1.17 -23.2%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$35.89M +19.4%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$94M – $96M $77.27M $65.17M $62.37M $47.56M $40.45MG $28.4M $25.36M
— $25.19M $21.24M $19.46M $16.31M $15.23M $10.71M $7.53M
— $52.08M $43.94M $42.91M $31.25M $25.22M $17.69M $17.83M
— 67.4% 67.42% 68.8% 65.71% 62.35% 62.29% 70.3%
— $34.22M $34.37M $36.97M $35.37M $26.58M $18.59M $15.02M
— $36.12M $29.37M $28.42M $28.27M $28.74M $17.43M $19.41M
— $52.56M $46.95M $53.3M $6.64M $5.33M $2.01M $2.77M
— $3.98M $4.58M $5.51M $3.79M $2.52M $1.76M $1.55M
— -$70.91M -$66.57M -$74.83M -$87.82M -$71.49M -$37.39M —
— -91.76% -102.14% -119.97% -184.66% -176.73% -131.64% —
— -$66.93M -$61.99M -$69.32M -$84.03M -$68.97M -$35.63M —
— -$77.49M -$61.27M -$78.5M -$87.59M -$73.51M -$41.23M -$33.63M
— $1.51M $1.22M $486K -$136K $168K -$1.89M $162K
— -$79M -$62.49M -$78.98M -$87.45M -$73.68M -$39.34M -$33.79M
— -102.24% -95.89% -126.63% -183.87% -182.14% -138.52% -133.23%
USD/shares — -$1.17 -$0.95 -$1.22 -$1.36 -$1.33 -$0.93 —
USD/shares — -$1.17 -$0.95 -$1.22 -$1.36 -$1.33 -$0.93 —
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2025-12-31 USD 15,287,000 20-F filed 2026-03-03
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
USD 2,700,000
Noncurrent lease liabilities
USD 12,587,000
Noncurrent long-term borrowings 2025-12-31 USD 47,733,000 20-F filed 2026-03-03
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1840706 CUSIP H82027105 13F (30d) 1 filings 1 filers Visit website Investor relations